Plain-English translation of NCT06399874 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two very different approaches to treating nightmares and sleep problems that happen after experiencing trauma. One approach uses a type of talk therapy called Nightmare Deconstruction and Reprocessing (NDR), which helps you process nightmare memories through guided exposure. The other uses a wristband device called NightWare that detects physical signs of a nightmare happening and gently vibrates to rouse you without fully waking you up.
Nightmares and sleep disturbances after trauma are common, long-lasting, and often don't respond well to current treatments. This trial exists to find out whether these two newer approaches—one using therapy and one using technology—could help people, especially those in military or remote settings where treatment options are limited.
You likely qualify if…
You likely don't qualify if…
You would commit to 18 weeks total: 6 weeks of baseline observation (with weekly check-ins), followed by 6 weeks of active treatment in either the therapy or wristband group, and then 6 weeks of follow-up assessments. During the treatment phase, you'll either attend weekly therapy sessions focused on your nightmares or use the wristband nightly and attend brief check-in appointments. The study also involves providing blood samples at certain times so researchers can measure biological markers of stress.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States